Medical News

Hodgkin Lymphoma in a Summary of News from Post-ASH 2021

28. 3. 2022 Source: Hematologic Malignancies

Dr. Anna Suredová from the Clinical Hematology Department of the Catalonian Oncology Institute in Barcelona, newly elected president of the European Society for Bone Marrow Transplantation (EBMT), also remotely participated in this year's Prague Hematology Days (PHD 2022). In her lecture, she presented an overview of highlights from 4 clinical studies regarding Hodgkin lymphoma (HL) presented during the Post-ASH 2021 meeting.

Current Insights into the Etiology of Community Pneumonia: Pneumococci Still Leading?

The etiology of community-acquired pneumonias has undergone certain changes since the beginning of the antibiotic era. According to current guidelines, it is still recommended to initiate empirical…

25. 3. 2022 Source: Anti-Infectives

Safe Long-term Treatment of Nasal Symptoms in Patients with Perennial Allergic Rhinitis

In persistent allergic rhinitis, achieving symptom control is often difficult despite pharmacological treatment and minimizing contact with the allergen. Good efficacy in clinical studies has been…

24. 3. 2022 Source: Life Without Allergic Rhinitis

Effect of Combination Therapy on Symptoms of Allergic Rhinitis

The aim of the study presented below by authors from the USA was to evaluate the efficacy, safety, and tolerability of treatment with the nasal spray GSP301 containing a fixed combination of active…

24. 3. 2022 Source: Life Without Allergic Rhinitis

Telmisartan –⁠ antihypertensive with cardioprotective effects

Sartans are potent inhibitors of the AT1 receptor for angiotensin II widely used in the therapy of arterial hypertension. Given that chronic activation of the renin-angiotensin-aldosterone system…

24. 3. 2022 Source: Sartans in the Treatment of Hypertension

Does the choice of therapy for primary hypertension in patients with COVID-19 affect the severity of the disease?

The effect of two commonly used antihypertensives was evaluated in a randomized clinical trial in patients with primary hypertension and COVID-19.

24. 3. 2022 Source: Sartans in the Treatment of Hypertension

Prim. Pavel Jindra: Biosimilars are an accessible and effective treatment modality in hematooncology

“Based on our experience so far, biosimilars represent an effective and safe alternative to original molecules. We are not afraid to use them anywhere in approved indications, and we are not afraid…

24. 3. 2022 Source: Oncological Treatment

You can confirm or exclude ATTRv amyloidosis through genetic testing

16. 3. 2022 Source: Rare Diseases

Combined Hormonal Contraception in the Treatment of Dysmenorrhea

Dysmenorrhea troubles many women of reproductive age and can deteriorate their quality of life, making it important for doctors to offer suitable therapy. We summarize the findings of research on the…

15. 3. 2022 Source: Oral Contraception

Parenteral Nutrition in Oncological Patients in Current ESPEN Recommendations

The current guidelines of the European Society for Clinical Nutrition and Metabolism (ESPEN) address nutritional care in oncological patients −⁠ current knowledge is summarized in a total of 43…

15. 3. 2022 Source: Parenteral Nutrition

Rakovina_pacientka s šátkem_ lékař vysvětluje_ diagnóza

Parenteral Nutrition as Part of Cancer Patient Treatment

Malnutrition represents a potentially serious complication for cancer patients. If it is not possible to meet the nutritional demands of the body through the enteral route, parenteral nutrition must…

15. 3. 2022 Source: Parenteral Nutrition

Why can probiotics and vitamin D significantly affect human health?

Vitamin D deficiency is the most common hypovitaminosis in developed countries. It is largely related to a lack of outdoor activity. Additionally, the typical Western diet does not support a healthy…

15. 3. 2022 Source: GI, colic and microbiome

Results of Knee and Hip Joint Arthroplasty in Hemophiliacs

Total endoprosthesis implantation represents an effective solution for the terminal stages of joint degeneration in hemophiliacs. However, compared to the general population, this group of patients…

15. 3. 2022 Source: Hemophilia with Movement

What Shape and Size of Tablets Do Our Patients Prefer?

The size and shape of tablets can affect patients' compliance with treatment. The following article provides an overview of conclusions from two foreign studies focused on influencing the difficulty…

14. 3. 2022 Source: Cardiovascular Continuum

How many heart failure patients do not take adequate doses of beta-blockers even though they could?

A British study published last year investigated the proportion of heart failure patients with reduced ejection fraction (HFrEF) who do not take an adequate dose of beta-blockers (BB), despite having…

14. 3. 2022 Source: Cardiovascular Continuum

1 … 55 56 57 58 59 … 111

Back Filter by speciality

Remove filters

Popular this week